Predicting breathing support failure with wearable monitoring
Part of Lungs & breathing clinical trials.
This study tests if a wearable chest monitor can predict when breathing support (like a mask or nasal prongs) might stop working, so doctors can act faster. It is for hospital patients who need help breathing but are not on a breathing tube.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently using a breathing support device (mask or high-flow nasal prongs) in the hospital.
- You do not have a long-term condition that causes high carbon dioxide levels in your blood.
- You do not have a muscle or nerve disease that affects breathing.
- You do not use a breathing machine at home (CPAP or BiPAP).
- You do not have a breathing tube in your windpipe, a pacemaker, defibrillator, or burns where the chest monitor would be placed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different ways to help you breathe without a breathing tube: helmet NIV, CPAP, or high-flow nasal oxygen. It aims to see which support works best for people who have sudden (acute) low oxygen levels.
This trial tests two ways to measure if non-invasive breathing support (a high-flow nasal cannula or a face mask) will work for patients with respiratory failure. The goal is to help doctors choose the right treatment sooner.
This study tests a new way to monitor breathing muscles in patients who need extra oxygen or breathing support, like a mask or high-flow oxygen. It may help doctors better understand how to treat respiratory failure.
This trial uses a non-invasive monitoring device to see if it can help predict when patients can safely have their breathing tube removed after upper abdominal surgery. The goal is to improve the success of coming off the ventilator.
This study looks at whether nighttime breathing problems can predict long-term success with a non-invasive breathing machine in people with COPD who have high carbon dioxide levels in their blood. The goal is to help doctors decide who will benefit most from this therapy.
This trial tests whether real-time monitoring with wearable devices can provide early warnings for COPD patients using home non-invasive ventilation. It aims to help manage the condition and prevent complications.
Hear when a new Ventilatory Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.